Neochem Bio Solutions Ltd

AI

Neochem Bio Solutions Ltd

₹ 106 1.05%
05 Nov - close price
About

Incorporated in 2006, Neochem Bio Solutions Ltd. is engaged in the business of manufacturing of specialty performance chemicals.[1]

Key Points

Business Profile:[1]
Operates as a specialty performance chemical company with 350+ customized formulations across four primary product segments, ''Polymers, Surfactants, Silicones
and esters /bio-based sustainable solutions''.
It has 50+ pan‑India authorized distributors, serving
225+ domestic customers, with customer presence
in 12 countries, 22,000 MTPA ISO‑certified capacity
in Ahmedabad, 40 registered trademarks, an in‑house
R&D lab, and a Zero Liquid Discharge facility.[2]

  • Market Cap ₹ 182 Cr.
  • Current Price ₹ 106
  • High / Low ₹ 121 / 63.0
  • Stock P/E 12.0
  • Book Value ₹ 50.6
  • Dividend Yield 0.00 %
  • ROCE 28.1 %
  • ROE 25.4 %
  • Face Value ₹ 10.0

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 28.8%

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has high debtors of 161 days.
  • Working capital days have increased from 77.8 days to 164 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Half Yearly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2025 Sep 2025 Mar 2026 Sep 2026
47 46 65 69
39 37 54 57
Operating Profit 8 9 11 12
OPM % 17% 19% 17% 17%
2 1 1 0
Interest 2 2 2 1
Depreciation 1 1 1 1
Profit before tax 7 7 10 10
Tax % 24% 25% 30% 25%
6 5 7 8
EPS in Rs 4.74 4.37 4.01 4.59
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
49 48 61 84 111 134
45 44 55 71 91 110
Operating Profit 4 4 6 13 20 23
OPM % 7% 9% 10% 15% 18% 17%
0 1 1 2 2 1
Interest 1 2 3 4 4 3
Depreciation 1 1 1 1 1 1
Profit before tax 1 2 3 10 17 20
Tax % 25% 28% 31% 25% 30%
1 1 2 7 12 15
EPS in Rs 1.87 1.20 1.65 6.36 7.03 8.60
Dividend Payout % 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 32%
TTM: 44%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 122%
TTM: 37%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: 28%
3 Years: 29%
Last Year: 25%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Equity Capital 3 5 7 7 17 17
Reserves 1 3 6 13 62 70
23 26 33 36 18 33
19 16 18 24 20 29
Total Liabilities 46 51 63 79 117 149
12 15 19 19 20 31
CWIP 0 0 0 0 0 3
Investments 0 0 0 0 6 5
34 36 45 60 91 110
Total Assets 46 51 63 79 117 149

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
-1 -1 -1 2 -17
-3 -3 12 -1 -9
4 4 -11 -1 26
Net Cash Flow 0 -0 0 -0 0
Free Cash Flow -4 -4 11 1 -19
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit -36% -23% -10% 23% -70%

Ratios

Standalone / View Consolidated

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 102 107 100 110 161
Inventory Days 141 173 172 157 143
Days Payable 186 155 142 111 56
Cash Conversion Cycle 58 125 131 156 247
Working Capital Days 17 19 30 39 164
ROCE % 12% 14% 26% 28%

Insights

In beta
Mar 2023 Mar 2024 Mar 2025 Mar 2026
Capacity Utilization
%

Log in to view insights

Please log in to see hidden values.

Login
Domestic Customer Count
count
Esters & Bio-based Segment Revenue Share
%
Home & Personal Care (HPC) Industry Revenue Share
%
Production Volume
MT
Textile Industry Revenue Share
%
R&D Expenditure (Percentage of Turnover)
%

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

2 Recently
Dec 2025Mar 2026Sep 2026
66.70% 66.72% 66.88%
1.99% 0.18% 0.18%
13.19% 15.82% 12.46%
18.12% 17.28% 20.47%
No. of Shareholders 861406525

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents